400mcg Sublingual Misoprostol as First Line Treatment

N/ACompletedNCT01939457

Gynuity Health Projects641 enrolled

Overview

Women presenting with incomplete abortion and eligible for treatment with misoprostol were offered 400mcg sublingual misoprostol for treatment. Based on existing literature, the study hypothesises that women can successfully be treated with misoprostol alone as first line treatment.

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

641

Conditions

Incomplete Abortion

Interventions

MisoprostolDRUG

Eligibility

Sex: FEMALEMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * uterine size less than 12 weeks lmp * open cervical os * current or past vaginal bleeding * willing to provide contact information for follow-up * over 18 or with guardian consent Exclusion Criteria: * suspicion of ectopic pregnancy * intrauterine device in place * bad general health (infection, anemia, shoc)

Locations (1)

Guediawaye Health Center

Guédiawaye, Senegal

Outcomes

Primary Outcomes

complete abortion

number of complete abortion with misoprostol treatment alone

Time frame: 1 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.